Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
Hookipa Biotech GmbH
Hookipa Biotech GmbH
Skin Analytics Limited
Revolution Medicines, Inc.
Advaxis, Inc.
Innovent Biologics (Suzhou) Co. Ltd.
Revolution Medicines, Inc.
Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany
Access Pharmaceuticals, Inc.
AstraZeneca
AstraZeneca